Sleep apnoea attenuates the effects of a lifestyle intervention programme in men with visceral obesity

被引:48
作者
Borel, Anne-Laure
Leblanc, Xavier [2 ]
Almeras, Natalie
Tremblay, Angelo
Bergeron, Jean [4 ]
Poirier, Paul
Despres, Jean-Pierre [3 ]
Series, Frederic [1 ]
机构
[1] Inst Univ Cardiol & Pneumol Quebec, Dept Pneumol, Ctr Rech, Quebec City, PQ G1V 4G5, Canada
[2] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada
[3] Univ Laval, Dept Social & Prevent Med, Div Kinesiol, Quebec City, PQ, Canada
[4] CHUQ Res Ctr, Lipid Res Ctr, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; LOW ENERGY DIET; METABOLIC SYNDROME; ADIPOSE-TISSUE; BLOOD-PRESSURE; HEART-FAILURE; LEPTIN LEVELS; RISK-FACTORS; WEIGHT-GAIN;
D O I
10.1136/thoraxjnl-2011-201001
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
100201 [内科学];
摘要
Background Excess visceral adiposity and sleep apnoea are two conditions independently associated with cardiovascular diseases. The two conditions are often combined and are believed to interact in a vicious circle. Objectives To compare the response of men with visceral obesity with or without sleep apnoea syndrome to a 1-year healthy eating, physical activity/exercise intervention programme. Methods 77 men, selected on the basis of increased waist circumference (>= 90 cm) and dyslipidaemia (triglycerides >= 1.69 and/or high-density lipoprotein (HDL) cholesterol <1.03 mmol/litre), participated in this study. Body composition and fat distribution were assessed by dual-emission X-ray absorptiometry or CT and sleep breathing disorders by home-based polygraphic recording. Cardiorespiratory fitness, plasma adipokines, plasma inflammatory markers, fasting lipoproteine-lipid profile and oral glucose tolerance test were assessed. Results After the 1-year lifestyle intervention, the mean oxygen desaturation index (ODI) of the whole sample decreased (-3 +/- 13 events/h, p<0.05). Men with sleep apnoea syndrome at baseline (ODI >= 10 events/h, n-28) showed smaller reductions in body mass index, waist circumference, triglycerides and smaller increases in HDL cholesterol and adiponectin than men without sleep apnoea (ODI <10 events/h, n-49), despite similar compliance to the programme. The higher the baseline ODI and the time spent under 90% saturation, the lower the reductions in fat mass and visceral adiposity, and the smaller the improvement in glucose/insulin homeostasis indices after 1 year. Conclusions Men with sleep apnoea syndrome at baseline had smaller reduction in body weight and less metabolic improvements associated with the lifestyle intervention programme than men without sleep apnoea syndrome.
引用
收藏
页码:735 / 741
页数:7
相关论文
共 39 条
[1]
[Anonymous], ACSMS GUID EX TEST P
[2]
Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea [J].
Arzt, Michael ;
Young, Terry ;
Finn, Laurel ;
Skatrud, James B. ;
Ryan, Clodagh M. ;
Newton, Gary E. ;
Mak, Susanna ;
Parker, John D. ;
Floras, John S. ;
Bradley, T. Douglas .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (16) :1716-1722
[3]
Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome [J].
Carneiro, Glaucia ;
Togeiro, Sonia Maria ;
Hayashi, Lilian F. ;
Ribeiro-Filho, Fernando Flexa ;
Ribeiro, Artur Beltrame ;
Tufik, Sergio ;
Zanella, Maria Teresa .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (02) :E380-E384
[4]
Risk Factors for Adult Overweight and Obesity in the Quebec Family Study: Have We Been Barking Up the Wrong Tree? [J].
Chaput, Jean-Philippe ;
Leblanc, Claude ;
Perusse, Louis ;
Despres, Jean-Pierre ;
Bouchard, Claude ;
Tremblay, Angelo .
OBESITY, 2009, 17 (10) :1964-1970
[5]
Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy [J].
Chin, KZ ;
Shimizu, K ;
Nakamura, T ;
Narai, N ;
Masuzaki, H ;
Ogawa, Y ;
Mishima, M ;
Nakamura, T ;
Nakao, K ;
Ohi, M .
CIRCULATION, 1999, 100 (07) :706-712
[6]
Despres J P, 1998, Obes Res, V6 Suppl 1, p8S
[7]
Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887
[8]
Effect of Rimonabant on the High-Triglyceride/Low-HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat The ADAGIO-Lipids Trial [J].
Despres, Jean-Pierre ;
Ross, Robert ;
Boka, Gabor ;
Almeras, Natalie ;
Lemieux, Isabelle .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (03) :416-423
[9]
ASSESSMENT OF ADIPOSE-TISSUE DISTRIBUTION BY COMPUTED AXIAL-TOMOGRAPHY IN OBESE WOMEN - ASSOCIATION WITH BODY DENSITY AND ANTHROPOMETRIC MEASUREMENTS [J].
FERLAND, M ;
DESPRES, JP ;
TREMBLAY, A ;
PINAULT, S ;
NADEAU, A ;
MOORJANI, S ;
LUPIEN, PJ ;
THERIAULT, G ;
BOUCHARD, C .
BRITISH JOURNAL OF NUTRITION, 1989, 61 (02) :139-148
[10]
A Randomized Study on the Effect of Weight Loss on Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes The Sleep AHEAD Study [J].
Foster, Gary D. ;
Borradaile, Kelley E. ;
Sanders, Mark H. ;
Millman, Richard ;
Zammit, Gary ;
Newman, Anne B. ;
Wadden, Thomas A. ;
Kelley, David ;
Wing, Rena R. ;
Pi-Sunyer, F. Xavier ;
Reboussin, David ;
Kuna, Samuel T. .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (17) :1619-1626